Frequency and characteristics of short versus longitudinally extensive myelitis in adults with MOG antibodies: A retrospective multicentric study.


Journal

Multiple sclerosis (Houndmills, Basingstoke, England)
ISSN: 1477-0970
Titre abrégé: Mult Scler
Pays: England
ID NLM: 9509185

Informations de publication

Date de publication:
07 2020
Historique:
pubmed: 1 6 2019
medline: 29 7 2021
entrez: 1 6 2019
Statut: ppublish

Résumé

We aim to (1) determine the frequency and distinctive features of short myelitis (SM) and longitudinally extensive transverse myelitis (LETM) in a cohort of adults with myelin oligodendrocyte glycoprotein (MOG)-antibody (Ab)-associated myelitis and (2) determine baseline prognostic factors among MOG-Ab-positive patients whose disease started with myelitis. We retrospectively analyzed clinical and paraclinical variables from a multicentric French cohort of adults with MOG-Ab-associated myelitis. At last follow-up, patients were classified into two groups according to the severity of the Expanded Disability Status Scale (EDSS) as ⩽2.5 or ⩾3.0. Seventy-three patients with at least one episode of myelitis over disease course were included; among them, 28 (38.4%) presented with SM at the time of the first myelitis. Motor and sphincter involvement was less frequently observed in SM (51.9% and 48.2%, respectively) than in LETM patients (83.3% and 78.6%, respectively), SM in MOG-Ab-associated disease is not rare. The severity at onset was the only independent factor related to the final prognosis in MOG-Ab-associated myelitis.

Identifiants

pubmed: 31148523
doi: 10.1177/1352458519849511
doi:

Substances chimiques

Autoantibodies 0
MOG protein, human 0
Myelin-Oligodendrocyte Glycoprotein 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

936-944

Auteurs

Jonathan Ciron (J)

Department of Neurology, Centre de Ressources et Compétences Sclérose en Plaques, Toulouse University Hospital, Toulouse, France.

Alvaro Cobo-Calvo (A)

Pathologies de la Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, Lyon, France; Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle and INSERM U1028, CNRS UMR 5292, Lyon 1 University, Center for Research in Neuroscience of Lyon, Lyon, France.

Bertrand Audoin (B)

Department of Neurology, Hôpital de La Timone, APHM, Marseille, France; Aix-Marseille University, Marseille, France.

Bertrand Bourre (B)

Department of Neurology, Rouen University Hospital, Rouen, France.

David Brassat (D)

Department of Neurology, Centre de Ressources et Compétences Sclérose en Plaques, Toulouse University Hospital, Toulouse, France.

Mikael Cohen (M)

Centre de Ressources et Compétences SEP, Neurologie, Université Nice Côte d'Azur, CHU Pasteur 2, Nice, France.

Nicolas Collongues (N)

Department of Neurology, Strasbourg University Hospital, Strasbourg, France.

Romain Deschamps (R)

Department of Neurology, Fondation A. De Rothschild, Paris, France.

Françoise Durand-Dubief (F)

Department of Neurology, Hôpital Neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France.

David Laplaud (D)

Department of Neurology, Nantes University Hospital, Nantes, France.

Elisabeth Maillart (E)

Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France.

Caroline Papeix (C)

Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France.

Hélène Zephir (H)

Department of Neurology, Lille University Hospital, Lille, France; LIRIC UMR 995, Lille, France.

Matthieu Bereau (M)

Department of Neurology, Besançon University Hospital, Besançon, France.

Bruno Brochet (B)

Department of Neurology, Bordeaux University Hospital, Bordeaux, France.

Clarisse Carra-Dallière (C)

Department of Neurology, Montpellier University Hospital, Montpellier, France.

Nathalie Derache (N)

Department of Neurology, Caen University Hospital, Caen, France.

Clarisse Gagou-Scherer (C)

Department of Neurology, Angers University Hospital, Angers, France.

Carole Henry (C)

Department of Neurology, Paris Saint-Denis Hospital, Paris, France.

Philippe Kerschen (P)

Department of Neurology, Centre Hospitalier Luxembourg, Luxembourg.

Guillaume Mathey (G)

Department of Neurology, Nancy University Hospital, Nancy, France.

Nicolas Maubeuge (N)

Department of Neurology, Poitiers University Hospital, Poitiers, France.

Aude Maurousset (A)

Department of Neurology, Tours University Hospital, Tours, France.

Alexis Montcuquet (A)

Department of Neurology, Limoges University Hospital, Limoges, France.

Thibault Moreau (T)

Department of Neurology, Dijon University Hospital, Dijon, France.

Christophe Prat (C)

Department of Neurology, Angoulême Hospital, Angoulême, France.

Frédéric Taithe (F)

Department of Neurology, Clermont-Ferrand University Hospital, Clermont-Ferrand, France.

Eric Thouvenot (E)

Department of Neurology, Nîmes University Hospital, Nîmes, France.

Ayman Tourbah (A)

CHU de Reims and Université Reims Champagne Ardenne, LPN, EA 2027 Université Paris 8, Saint-Denis, France.

Fabien Rollot (F)

Claude Bernard Lyon 1 University, Villeurbanne, France.

Sandra Vukusic (S)

Pathologies de la Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, Bron, France; Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle and INSERM U1028, CNRS UMR 5292, Lyon 1 University, Center for Research in Neuroscience of Lyon, Lyon, France.

Romain Marignier (R)

Service de Neurologie, Sclérose en Plaques, Pathologies de la Myéline et Neuro-inflammation, Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, Bron, France; Centre de Référence des Maladies Inflammatoires Rares du Cerveau et de la Moelle and INSERM U1028, CNRS UMR 5292, Lyon 1 University, Center for Research in Neuroscience of Lyon, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH